Singapore- Versartis and Aravive Biologics jointly announced that they have entered into a definitive agreement under wh...
Singapore- Blueprint Medicines and CStone Pharmaceuticals, a privately-held biopharmaceutical company announce an e...
Singapore- Eli Lilly and Company and Incyte Corporation announced that the U.S. Food and Drug Administration (FDA) has a...
Singapore- Amgen, in a two-sentence announcement, said it received a complete response letter for the biosimilar of Roch...
Global drug giant, Roche recently announced that the European Commission has approved Perjeta (pertuzumab) in combinatio...
LUYE PHARMA announced that the Group entered into a collaboration and license agreement with Elpis Biopharm, a Boston-re...
Singapore- U.S. regulators approved BioMarin Pharmaceutical Inc’s Palynziq for adults with phenylketonuria, a rare...
Eisai Inc. and Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced that the U.S. Food and Dr...
Singapore- Celgene and German biotech Evotec AG have inked a long-term strategic drug discovery and development par...
Global drug giant, AstraZeneca has submitted a supplemental new drug application (sNDA) to Japan’s Pharmaceuticals...
Singapore- Minerva Neurosciences, a clinical-stage biopharmaceutical company focused on the development of therapi...
Singapore- The European Commission (EC) has approved commercialization partner Ipsen's marketing application for C...
Singapore- Regeneron Pharmaceuticals and development partner Sanofi announce positive preliminary data from a...
Singapore- Dicerna Pharmaceutical’s drug recently received an orphan drug status designation for i...
Singapore- The U.S. Food and Drug Administration approved privately held US WorldMeds LLC's Lucemyra (lofexidine hydroch...
Singapore– Daré Bioscience, a clinical-stage women’s biopharmaceutical company has agreed t...
Kindred Biosciences, Inc. a biopharmaceutical company focused on saving and improving the lives of pets, announced that ...
Singapore – Shanghai-based Zai Lab Limited inks an exclusive license agreement with privately held Entasis Therape...
